Back to Search
SILVA MARKOVIC-PLESE, MD
MD
Neurological Surgery Physician
NPI: 1255403747IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology Physician
Psychiatry & Neurology — Neurology
Code: 2084N0400X
300655(NC)
Neurological Surgery PhysicianPrimary
Neurological Surgery
Code: 207T00000X
MD465884(PA)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 1988
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
PMID 19297658·Neuroscientist·2009
8-other
High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis.
PMID 16150497·J Neuroimmunol·2005
4-observational
The initiation of the autoimmune response in multiple sclerosis.
PMID 15177771·Clin Neurol Neurosurg·2004
6-review
Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.
PMID 18977698·Clin Immunol·2009
8-other
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis.
PMID 19487658·Neurology·2009
8-other
IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
PMID 19265172·J Immunol·2009
8-other
Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy.
PMID 19021074·J Neurovirol·2008
5-case
Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response.
PMID 18484192·Immunol Res·2008
6-review
Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.
PMID 18453621·J Immunol·2008
8-other
Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
PMID 18412170·Eur J Immunol·2008
8-other
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
PMID 16870268·J Neuroimmunol·2006
8-other
Acute disseminated encephalomyelitis after liver transplantation.
PMID 15824267·Arch Neurol·2005
5-case
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.
PMID 15161974·Proc Natl Acad Sci U S A·2004
3-trial
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
PMID 15145635·Lancet·2004
3-trial
Longitudinal MRI study: the effects of azathioprine in MS patients refractory to interferon beta-1b.
PMID 12796549·Neurology·2003
3-trial
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.
PMID 12651870·Hum Mol Genet·2003
8-other
Immunopathogenesis of the multiple sclerosis lesion.
PMID 11898527·Curr Neurol Neurosci Rep·2001
6-review
CD4+CD28- costimulation-independent T cells in multiple sclerosis.
PMID 11602626·J Clin Invest·2001
8-other
Dendritic cells signal T cells in the absence of exogenous antigen.
PMID 11561182·Nat Immunol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 900 WALNUT ST FL 2
PHILADELPHIA, PA 19107 - Phone
- (215) 955-1234
Quick Facts
- NPI
- 1255403747
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 38
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile